Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs remimazolam vs propofol for early recovery after gynecologic laparoscopic surgery
ChiCTR2200064374Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Oct 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol, remimazolam and propofol in nonelective condition (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: QoR-15 score. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
ciprofolremimazolampropofol
03
Conditions
nonelective condition
Beyond the preview
Go deeper on ChiCTR2200064374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064374.